Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy (2016)
- Authors:
- Peres, Fernanda F. - Universidade Federal de São Paulo (UNIFESP)
- Levin, Raquel - Universidade Federal de São Paulo (UNIFESP)
- Almeida, Valéria - Universidade Federal de São Paulo (UNIFESP)
- Zuardi, Antônio Waldo
- Hallak, Jaime Eduardo Cecílio
- Crippa, José Alexandre de Souza
- Abilio, Vanessa C. - Universidade Federal de São Paulo (UNIFESP)
- USP affiliated authors: ZUARDI, ANTONIO WALDO - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP
- Unidade: FMRP
- DOI: 10.3389/fphar.2016.00303
- Subjects: CANABINOIDES; MODELOS ANIMAIS; ESQUIZOFRENIA
- Keywords: Prepulse inhibition of startle reflex; Animal models; Schizophrenia; Cannabidiol; Endocannabinoidsystem; SHR strain
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Pharmacology
- ISSN: 1663-9812
- Volume/Número/Paginação/Ano: v. 7, art. 303, 2016
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
PERES, Fernanda F. et al. Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy. Frontiers in Pharmacology, v. 7, 2016Tradução . . Disponível em: https://doi.org/10.3389/fphar.2016.00303. Acesso em: 24 jan. 2026. -
APA
Peres, F. F., Levin, R., Almeida, V., Zuardi, A. W., Hallak, J. E. C., Crippa, J. A. de S., & Abilio, V. C. (2016). Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy. Frontiers in Pharmacology, 7. doi:10.3389/fphar.2016.00303 -
NLM
Peres FF, Levin R, Almeida V, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2026 jan. 24 ] Available from: https://doi.org/10.3389/fphar.2016.00303 -
Vancouver
Peres FF, Levin R, Almeida V, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2026 jan. 24 ] Available from: https://doi.org/10.3389/fphar.2016.00303 - Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia
- Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system
- Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion
- Cannabidiol, a nonpsychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury
- Interaction between cannabidiol (CBD) and 'delta 9'-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids [Carta]
- Reprint of “Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)”
- Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: reversal by cannabidiol
- Cannabidiol was ineffective for manic episode of bipolar affective disorder
Informações sobre o DOI: 10.3389/fphar.2016.00303 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
